Back
Solid Biosciences, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
37
SLDB
Solid Biosciences, Inc.
Last Price:
$5.28
Seasonality Move:
-12.68%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atSolid Biosciences, Inc. Stock Forecast
-
Over the next 52 weeks, Solid Biosciences, Inc. has on average historically fallen by 21.4% based on the past 7 years of stock performance.
-
Solid Biosciences, Inc. has fallen lower in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Solid Biosciences, Inc. Stock Undervalued?The current Solid Biosciences, Inc. [SLDB] share price is $5.29. The Score for SLDB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
SLDB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Solid Biosciences, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Solid Biosciences, Inc. has on average historically fallen by 21.4% based on the past 7 years of stock performance.
Solid Biosciences, Inc. Stock Rating
Sell
37
Solid Biosciences, Inc. (SLDB)
is a Sell
Is Solid Biosciences, Inc. overpriced?
-
Solid Biosciences, Inc. has fallen lower in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Solid Biosciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
solidbio.com
52-Week Data
52-Week High:
7.37
52-Week Low:
2.41
Prediction Charts
Market Cap:
412.1M
Price in USD:
5.29
Volume:
656.7K
Beta:
1.93
Technical Analysis
SMA50:
5.22
SMA100:
5.47
SMA200:
4.95
52-Wk Change:
31.27%
Stock Predictions
-
Is Solid Biosciences, Inc. stock public?Yes, Solid Biosciences, Inc. is a publicly traded company.
-
What is the Solid Biosciences, Inc. stock quote today?The Solid Biosciences, Inc. stock price is 5.29 USD today.
-
How to buy Solid Biosciences, Inc. stock online?You can buy Solid Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-19 | 5.32 | 5.94 | 6.11 | 5.28 |
| Dec-22 | 5.90 | 5.98 | 6.24 | 5.82 |
| Dec-23 | 5.89 | 5.90 | 5.97 | 5.68 |
| Dec-24 | 5.83 | 5.90 | 6.07 | 5.83 |
| Dec-26 | 5.88 | 5.84 | 5.97 | 5.76 |
| Dec-29 | 5.73 | 5.69 | 5.82 | 5.61 |
| Dec-30 | 5.65 | 5.70 | 5.85 | 5.60 |
| Dec-31 | 5.66 | 5.64 | 5.78 | 5.63 |
| Jan-2 | 5.73 | 5.45 | 5.77 | 5.40 |
| Jan-5 | 5.43 | 5.33 | 5.49 | 5.17 |
| Jan-6 | 5.31 | 5.49 | 5.53 | 5.27 |
| Jan-7 | 5.51 | 5.61 | 5.77 | 5.48 |
| Jan-8 | 5.60 | 5.31 | 5.60 | 5.23 |
| Jan-9 | 5.37 | 5.29 | 5.50 | 5.17 |
Solid Biosciences, Inc. Earnings
Solid Biosciences, Inc. Earnings Report: Per Share Solid Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Solid Biosciences, Inc. Forecast Revenue Growth
Solid Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Solid Biosciences, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.09 per share.
* Solid Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.